Rev1 Ventures is a venture studio based in Columbus, Ohio that combines capital and strategic services to help startups scale and corporates innovate. The firm partners with innovators in SaaS/AI, deep tech, and life sciences to turn bold ideas into scalable companies.
They made 1 investment in the last 12 months. Average disclosed round size is $14.4M (across 33 rounds with reported amounts).
Portfolio
31
Fund Size
$20M
Top Stage
Seed
Last 12 Mo
1
Team
Kim Zavislak
Columbus Office Managing Partner
Alicia Oddi
Managing Director, Venture Services
Andrea O’Carroll
Managing Director, Venture Platform
Carol Curtis, PhD
Advisory Partner
David Bergeron
Advisory Partner, Advanced Technologies
Greg Pugh
Advisory Partner. Software and Advanced Technologies
Parker MacDonell
Advisory Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| RRednox | Seed | $1.7M | Oct 2025 |
 Nichefire | Seed | $2.6M | Jan 2025 |
 Power to Hydrogen | Series A | $18M | Aug 2024 |
 HubiFi | Seed | $2.5M | Aug 2024 |
 Niobium | Seed | $5.5M | May 2024 |
 CHAMPtitles | Series C | $18M | Mar 2024 |
 Redi Health | Series B | $14M | Feb 2024 |
 LENTECHS | Seed | $6M | Oct 2023 |
 SureImpact | Seed | $2M | May 2023 |
 STAQ Pharma | Series C | $45M | Jan 2023 |
 Invirsa | Series B | $7.7M | Jan 2023 |
 Synota | Seed | $3M | Oct 2022 |
| LLucy Ai | Series A | $6M | Jan 2022 |
 Cape Analytics | Series C | $44M | Jul 2021 |
 Aware | Series C | $60M | Jan 2021 |
| Aware | Series B | $12M | Jan 2020 |
 Ubihere | Unknown | $875K | Jan 2020 |
| DDeep Lens | Seed | $3.2M | Jan 2018 |
| MMyonexus Therapeutics | Seed | $2.5M | Dec 2017 |
 Updox | Series B | $12.7M | May 2017 |
 Prevedere | Series B | $25M | Mar 2017 |
 Rapchat | Seed | $2.3M | — |
 Basking Biosciences | Unknown | $55M | — |
 Lucy | Series A | $6M | — |
| DDeep Lens | Series A | $14M | — |
Top Co-Investors
Last updated: 7 October 2026